Table 2.
The novel candidate agents under investigation for regulating the secretion of pulmonary mucus
| Classification of novel candidate agents | Compounds |
|---|---|
| Novel compounds and/or repositioned drugs targeting for regulating the secretion of pulmonary mucus under investigation | 11,12- epoxyeicosatrienoic acids (EET) (Lasker et al., 2000) |
| FK224 and CP99994 (Bertrand and Geppetti, 1996; Advenier et al., 1997) | |
| Sildenafil (Wang et al., 2009) | |
| Niflumic acid (Nakanishi et al., 2001; Zhou et al., 2002; Hauber et al., 2005b, 2007b) | |
| Blockers of P2Y2 purinoceptor (Davis, 2002) | |
| Peptides related to myristoylated alanine-rich C kinase substrate (MARCKS) (Singer et al., 2004; Green et al., 2011) | |
| Blockers of retinoic acid receptor (RAR)-α (Koo et al., 1999; Aggarwal et al., 2006) | |
| Natural products targeting for regulating the secretion of pulmonary mucus under investigation | 4′,7-dihydroxyflavone (Zhou et al., 2015) |
| Apigenin (Seo et al., 2014; Sikder et al., 2014b) | |
| Baicalein (Lee et al., 2003, 2004a, 2004b; Heo et al., 2007a) | |
| Baicalin (Heo et al., 2007a) | |
| Berberine (Sikder et al., 2011) | |
| Carbenoxolone (Heo et al., 2007b; Lee et al., 2011a) | |
| Chrysin (Shin et al., 2012) | |
| Coixol (Lee et al., 2015b) | |
| Curcumin (Heo et al., 2009) | |
| Daidzein (Lee et al., 2011c) | |
| Dioscin (Lee et al., 2015a) | |
| Ebeiedine (Kim et al., 2016) | |
| Genistein (Heo et al., 2009) | |
| Gingerol (Kim et al., 2009; Chang et al., 2010) | |
| Glyceryl trilinoleate (Lee et al., 2015b) | |
| Glycyrrhizin (Heo et al., 2007b; Nishimoto et al., 2010; Lee et al., 2011a) | |
| Hesperidin (Lee et al., 2003, 2004a, 2004b) | |
| Kaempferol (Kwon et al., 2009) | |
| Lobetyol (Yoon et al., 2014) | |
| Lobetyolin (Yoon et al., 2014) | |
| Lupenone (Yoon et al., 2015) | |
| Lupeol (Yoon et al., 2015) | |
| Luteolin (Lee et al., 2015c) | |
| Methyl linoleate (Yoon et al., 2014) | |
| Methylprotodioscin (Lee et al., 2015a) | |
| Morusin (Lee et al., 2014) | |
| Naringin (Nie et al., 2012) | |
| Obtusifolin (Choi et al., 2019) | |
| Oleanolic acid (Cho et al., 2011) | |
| Ophiopogonin D (Park et al., 2014) | |
| Platycodins (Shin et al., 2002; Choi et al., 2011; Ryu et al., 2014) | |
| Prunetin (Lee et al., 2011b; Ryu et al., 2013) | |
| Quercetin (Kwon et al., 2009; Yang et al., 2012) | |
| Resveratrol (Lee et al., 2012) | |
| Scutellarin (Jiang et al., 2011) | |
| Silibinin (Kim et al., 2012b) | |
| Spicatoside A (Park et al., 2014) | |
| Suchengbeisine (Kim et al., 2016) | |
| Taraxerol (Yoon et al., 2015) | |
| Tilianin (Song et al., 2017) | |
| Tussilagone (Choi et al., 2018) | |
| Ursolic acid (Cho et al., 2011) | |
| Verproside (Lee et al., 2015d) | |
| Verticine (Kim et al., 2016) | |
| Wogonin (Sikder et al., 2014a, 2014b) |